DOR binding is decreased in the amygdala and ventral putamen, and MOR binding is decreased in the hippocampus and subiculum (Mathieu-Kia et al., 2001) of postmortem brain samples from patients with AD. Here, OPRM1 is linked to Alzheimer disease.